Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC

Positions Available

Post-Doctoral Position at University of Rochester focused in Clinical Cancer Control and Survivorship Research


The Cancer Control and Psychoneuroimmunology Laboratory (CCPL) within the Department of Surgery at the University of Rochester Medical School and Wilmot Cancer Institute (WCI) is seeking exceptional candidates for a Post-Doctoral Associate position in the area of clinical (patient-oriented) cancer control and survivorship research.  The University of Rochester is located in the beautiful Finger Lakes region of upstate New York.  The position is available immediately and fully funded at a very competitive salary for a period of 2-3 years.  The successful applicant will work directly with the Laboratory Principal Investigator, Dr. Michelle Janelsins, and be part of an internationally renowned multidisciplinary cancer control research team comprised of oncologists, epidemiologists, immunologists, neuroscientists, clinical psychologists and biostatisticians among others.  Research in the CCPL consists of multiple clinical trials and cohort studies conducted locally/ and regionally through the WCI and nationally through the University of Rochester Cancer Center (URCC) NCI Oncology Research Program (NCORP) Research Base, where Dr. Janelsins oversees all translational research. 

The Cancer Control and Psychoneuroimmunology Laboratory is a state-of-the-art translational research lab led by Dr. Michelle Janelsins that is focused on several projects investigating the impact of cancer and its treatment on side effect management. Dr. Janelsins and colleagues are currently conducting several studies in this area including one of the largest longitudinal studies investigating the impact of chemotherapy on cognitive function in breast cancer and lymphoma patients including biological (e.g. immune, neurological, genetic, aging), psychological and clinical effects in patients compared to controls. Additionally, Dr. Janelsins is conducting intervention studies for alleviating cognitive problems experienced during chemotherapy.  Her work is supported by several NIH grants including the NIH Director’s Innovator Award (DP2). In addition to a focus on cognition and cancer, the lab is broadly interested in many aspects of research related to quality of life improvement and side effect management in cancer. We use a number of multidisciplinary approaches (i.e. basic and clinical) in psychoneuroimmunology, immunology, neuroscience, cognitive science, and psychology.

We are interested in candidates with a PhD degree in a variety of related backgrounds. Applicants who have experience or interest in translational research studies with biomarkers are strongly encouraged to apply. Successful applicants will have the opportunity to develop skills in translational clinical cancer control and survivorship research and implement a research project in this area.

Please send a 1-2 page personal statement describing the candidates’ research experience to date and interest in the position and a full CV to Dr. Michelle Janelsins: Please be prepared to share the name and contact info of 2-3 references that can speak to the candidates’ potential if selected for an interview.

The University of Rochester Medical Center is an Equal Opportunity/Affirmative Action Employer and strongly encourages applications from women and minority candidates.